Boston Scientific (BSX): Rep. Kevin Hern (OK01) disclosed a sale $1K–$15K
Rep. Kevin Hern (OK01) disclosed a sale of Boston Scientific in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 22 days
- Disclosure lag
- Traded
- Sep 3, 2026
- Disclosed
- Sep 25, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 4, 2025Federal contract · $601K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $601K obligated to date
- Dec 23, 2025Federal contract · $493K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $493K obligated to date
- Mar 27, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Jun 4, 2026CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Jul 16, 2026Federal contract · $608K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $608K obligated to date
- Jul 21, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“On July 21, 2026, the Board of Directors of Boston Scientific Corporation (the “Company”) approved a new global restructuring program (the “2026 Restructuring Plan”).”
- Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 31, 2026InsiderDirector purchased ~$227K of BSX shares in the open market
- Aug 3, 2026Insider · 2 peopleInsiders: 2 purchases (~$9.1M)
- Aug 4, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$6.8K of BSX shares in the open market
- Aug 5, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$100K of BSX shares in the open market
- Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 3.1%
- Aug 18, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Aug 25, 2026Insider · 13 days before an 8-KDirector purchased ~$100K of BSX shares in the open market
- Aug 31, 2026CongressDisclosed sale of BSX — reported range $15,001 - $50,000
- Sep 3, 2026 · this disclosureCongressDisclosed sale of BSX — reported range $1,001 - $15,000
What came next
- Sep 3, 2026Congress · 1 personMembers of Congress: 2 sales
- Sep 4, 2026CongressDisclosed partial sale of BSX — reported range $50,001 - $100,000
- Sep 7, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “ Company ”) identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations.”
- Sep 9, 2026CongressDisclosed sale of BSX — reported range $50,001 - $100,000
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/1RO/155; Material Number: M001195650
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/130; Material Number: M001195270
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/130; Material Number: M001195440
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/027/BERN/1RO/155; Material Number: M001195750
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/BERN/1RO/130; Material Number: M001195840
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/SWAN/1RO/130; Material Number: M001195500
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/155; Material Number: M001195310
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/1RO/130; Material Number: M001195640
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/J/1RO/155; Material Number: M001195480
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/2RO/155; Material Number: M001195330
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/130; Material Number: M001195210
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/155; Material Number: M001195280
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/130; Material Number: M001195300
- Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/BERN/1RO/105; Material Number: M001195230
- Sep 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027.”
- Sep 30, 2026FDARecall: Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation System
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
Other recent filings by Rep. Kevin Hern (OK01)
- House Clerk periodic transaction report at ASML Holding (ASML)Oct 28, 2026
- House Clerk periodic transaction report at Seagate Technology (STX)Oct 28, 2026
- House Clerk periodic transaction report at Texas Instruments (TXN)Oct 28, 2026
- House Clerk periodic transaction report at Marsh McLennan (MRSH)Oct 13, 2026
- House Clerk periodic transaction report at NextEra Energy (NEE)Oct 13, 2026
The full history of Rep. Kevin Hern (OK01) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Boston Scientific (BSX) stock, and how much?
Rep. Kevin Hern (OK01) disclosed a sale of Boston Scientific in the $1K–$15K range. Reported range, not an exact amount, Dependent child account.
When did it happen, and when was it made public?
Traded: Sep 3, 2026. Disclosed: Sep 25, 2026. That is 22 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
